BIOLASE Named as Finalist in the Medical Devices Category for TechAmerica High-Tech Innovation Awards
01 May 2012 - 11:00PM
Marketwired
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental
laser manufacturer and distributor, has been named a finalist in
the Medical Devices category for the TechAmerica Orange County
High-Tech Innovation Awards. Now in its 19th year, this premier
business event celebrates excellence and achievement in the
region's technology industry, and honors local companies,
individuals and products that drive innovation in Orange County.
This year's winners will be announced at a dinner on June 14, 2012,
at the Hilton in Costa Mesa, CA.
"We received nearly 100 nominations including start-up
innovators, high-growth companies and established industry players
from across Orange County," said Bob Brunson, director, TechAmerica
Orange County. "We congratulate BIOLASE for rising to the finalist
rank. This region is home to groundbreaking innovators, including
BIOLASE, that continue to influence technology development
throughout the rest of the world, and we're excited to help
highlight them."
Federico Pignatelli, Chairman and CEO, said, "Providing
innovative and disruptive technologies that advance the practice of
dentistry and medicine with a truly new and biological surgical
device that is leading to enhanced outcomes for far superior and
safer patient experiences, continues to be our focus at BIOLASE. We
are delighted that our Waterlase iPlus™ all-tissue dental laser
system is a finalist for innovative product/technology in the
medical devices category. The Waterlase iPlus, our flagship laser,
is the most advanced laser ever produced for dentistry and, with
its tremendous cutting speed and graphical intuitive user
interface, addresses a wide range of clinical procedures and can
truly change the practice and economics of dentistry."
For more information, please visit
www.techamerica.org/hta19.
About TechAmerica TechAmerica is the
leading voice for the U.S. technology industry -- the driving force
behind productivity growth and jobs creation in the United States
and the foundation of the global innovation economy. Representing
approximately 1,000 member companies of all sizes from the public
and commercial sectors of the economy, it is the industry's largest
advocacy organization and is dedicated to helping members' top and
bottom lines. TechAmerica is also the technology industry's only
grassroots-to-global advocacy network, with offices in state
capitals around the United States, Washington, D.C., Europe
(Brussels) and Asia (Beijing). Learn more about TechAmerica at
www.techamerica.org.
About BIOLASE Technology, Inc. BIOLASE
Technology, Inc., the World's leading Dental Laser Company, is a
medical technology company that develops, manufactures and markets
dental lasers and also distributes and markets dental imaging
equipment, products that are focused on technologies that advance
the practice of dentistry and medicine. The Company's laser
products incorporate 285 patented and patent pending technologies
designed to provide clinically superior performance with less pain
and faster recovery times. Its imaging products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
dental laser systems that perform a broad range of dental
procedures, including cosmetic and complex surgical applications,
and a full line of dental imaging equipment. BIOLASE has sold more
than 19,000 lasers among 16,000 customers. Other products under
development address ophthalmology and other medical and consumer
markets.
For updates and information on laser and Waterlase dentistry,
find BIOLASE at http://www.biolase.com, Twitter at
http://twitter.com/GoWaterlase, and YouTube at
http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within
the meaning of safe harbor provided by the Securities Reform Act of
1995 that are based on the current expectations and estimates by
BIOLASE management. These forward-looking statements can be
identified through the use of words such as "anticipates,"
"expects," "intends," "plans," "believes," "seeks," "estimates,"
"may," "will," and variations of these words or similar
expressions. Forward-looking statements are based on management's
current, preliminary expectations and are subject to risks,
uncertainties and other factors which may cause the Company's
actual results to differ materially from the statements contained
herein, and are described in the Company's reports it files with
the Securities and Exchange Commission, including its annual and
quarterly reports. No undue reliance should be placed on
forward-looking statements. Such information is subject to change,
and BIOLASE undertakes no obligation to update such statements.
For further information on BIOLASE, please contact: Jill
Bertotti Allen & Caron +1-949-474-4300 For TechAmerica Orange
County: Cara Stewart Binary Pulse Technology Marketing
+1-949-336-7400 carastewart@binarypulse.com
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From May 2024 to Jun 2024
Biolase (NASDAQ:BLTI)
Historical Stock Chart
From Jun 2023 to Jun 2024